Synektik S.A.

Emerging Competitors in Robotic Surgery Market Challenge Industry Leaders

The recent Society of Robotic Surgery (SRS) conference showcased a wave of new entrants in the robotic surgery market, particularly from Asia, aiming to challenge the dominance of Intuitive Surgical's da Vinci system. Over 100 companies presented their innovations, including advanced robotic systems for soft tissue surgery, non-invasive procedures, and diagnostic tools. Among the notable players were:

• Agibot (China): A Shanghai-based company with a 4-arm surgical robot featuring a 4K 3D vision system and over 300 patents. Its robots have already facilitated over 2,000 surgeries in Chinese hospitals.
• Riverfield (Japan): Introduced the Saroa robot with a unique hydraulic drive system providing haptic feedback. The system is operational in Japanese hospitals and recently received certifications for Thailand and Malaysia.
• LivsMed Surgical (South Korea): Debuted the Stark system, a hybrid of columnar and modular robots, with highly flexible tools and plans to enter the U.S. market with FDA certification.
• Wynex and Carina (China): Wynex, developed by Kangjii Medical, features a 4-arm system with 30 tools, while Carina, by Ronovo Surgical, offers a columnar robot with up to 5 arms, already used in over 1,000 surgeries.

Additionally, European and American companies are targeting cost-effective solutions for ambulatory surgical centers (ASC). British firm CMR Surgical's Versius, Swiss company Distalmotion's Dexter, and U.S.-based Moon Surgical and Momentis Surgical are focusing on compact, modular, and affordable systems. Johnson & Johnson also unveiled its Ottava robot, designed for ergonomic integration into operating rooms.

The U.S. market, particularly ASCs, is becoming a hotspot for these new players, driven by demand for simpler, cost-efficient robotic systems for outpatient procedures.

Relevance to Synektik S.A.: The growing competition in the robotic surgery market underscores the importance of Synektik S.A.'s exclusive distribution of the da Vinci system in Poland, highlighting the need to maintain its competitive edge amidst emerging global players. This trend also aligns with Synektik's focus on advanced medical technologies and innovation in healthcare solutions.

Key Capital Market Events Scheduled for August 2026

The upcoming week on the Warsaw Stock Exchange (GPW) features several significant events for investors and stakeholders. Key highlights include:

• Monday, August 3: CEZ will distribute a dividend of 42.0 CZK per share, and MENTZEN will pay a dividend of 0.87 PLN per share.
• Tuesday, August 4: SECOGROUP will hold an extraordinary general meeting to discuss amendments to the remuneration policy for board members and the supervisory board.
• Wednesday, August 5: STALEXP will convene an extraordinary general meeting to deliberate on reducing share capital and amending its statute. MERCATOR will distribute a dividend of 1.64 PLN per share, while PKOBP will pay a dividend of 6.14 PLN per share.
• Thursday, August 6: AILLERON and PANOVA will hold extraordinary general meetings to address changes in their supervisory boards. TEXT will conduct its annual general meeting. Dividends will also be distributed by GPW (3.40 PLN per share) and UNIBEP (0.40 PLN per share).

These events highlight the dynamic nature of the Polish capital market, offering opportunities for investors to engage with various companies across industries.

Relevance to Synektik S.A.: As a publicly listed company on the GPW, Synektik S.A. operates in a competitive market environment. Monitoring capital market activities is crucial for understanding industry trends and positioning the company strategically among its peers.

Key Events on NewConnect Market Calendar for August 2026

The NewConnect market calendar for the week of August 3, 2026, highlights several significant corporate events. On Tuesday, August 4, SUNNET will hold its Ordinary General Meeting at 9:00 AM. On Wednesday, August 5, BASEIG will convene an Extraordinary General Meeting at 12:00 PM to discuss the appointment of a new supervisory board member and amendments to the company's statute. On the same day, VOOLT will also hold its Ordinary General Meeting at 12:00 PM. Lastly, on Thursday, August 6, LTGAMES will continue its Ordinary General Meeting, which began on July 8, 2026. Additionally, EDITELPL has announced a dividend payout of 0.44 PLN per share, with the dividend day set for August 6.

Relevance to Synektik S.A.: The NewConnect market calendar provides insights into the broader financial and corporate environment in which Synektik S.A. operates, offering potential opportunities for strategic partnerships or market positioning within the medical technology sector.

Key Events on the Warsaw Stock Exchange Calendar for July 31, 2026

The Warsaw Stock Exchange (GPW) has announced a series of significant events scheduled for the week starting July 31, 2026. These include extraordinary general meetings, dividend payouts, and corporate decisions impacting various companies. Notable events include:

• July 31: Extraordinary general meetings for CRQUANTUM and ENEA, focusing on share buybacks and company restructuring. Dividend payouts are scheduled for ARCHICOM (1.80 PLN per share), FEERUM (0.50 PLN per share), ODLEWNIE (0.45 PLN per share), PANOVA (1.00 PLN per share), and ZABKA (0.12 EUR per share).
• August 3: CEZ will distribute a dividend of 42.0 CZK per share, while MENTZEN will pay 0.87 PLN per share.
• August 4: SECOGROUP will hold an extraordinary general meeting to revise executive compensation policies.
• August 5: STALEXP will discuss capital reduction, and MERCATOR will pay a dividend of 1.64 PLN per share. PKOBP will distribute 6.14 PLN per share as dividends.
• August 6: AILLERON and PANOVA will hold extraordinary general meetings to address board changes. GPW will pay a dividend of 3.40 PLN per share, and UNIBEP will distribute 0.40 PLN per share.

These events reflect ongoing corporate governance activities and financial distributions across various sectors, showcasing the dynamic nature of the Polish capital market.

Relevance to Synektik S.A.: While Synektik S.A. is not directly mentioned, the focus on dividend payouts and corporate governance highlights the importance of financial stability and strategic decision-making, which are critical for companies like Synektik operating in the competitive medical technology sector.

Key Events on NewConnect Market Calendar for July 31, 2026

The NewConnect market calendar for July 31, 2026, highlights several significant events for investors. Among the key updates:

• Balticon: Dividend payout of 0.22 PLN per share.
• BSH: Dividend payout of 1.00 PLN per share.
• Klepsydra: Dividend payout of 0.04 PLN per share.

Additionally, upcoming shareholder meetings include:

• Sunnet: Ordinary General Meeting on August 4 at 9:00 AM.
• Baseig: Extraordinary General Meeting on August 5 at 12:00 PM to discuss board member appointments and statute changes.
• Voolt: Ordinary General Meeting on August 5 at 12:00 PM.
• LTGames: Continuation of the General Meeting from July 8, scheduled for August 6 at 12:00 PM.
• EditelPL: Dividend payout of 0.44 PLN per share on August 6.

These updates provide a snapshot of key financial and governance activities within the NewConnect market.

Relevance to Synektik S.A.: While Synektik S.A. is not directly mentioned in this calendar, the financial and governance updates on the NewConnect market are relevant as they reflect the broader investment environment in Poland, which could influence investor sentiment and market dynamics for companies like Synektik S.A.

Synektik S.A. Announces Q3 FY2025 Financial Results Conference

Synektik S.A., a leading Polish medical technology company specializing in radiopharmaceutical production, medical equipment distribution, and healthcare IT solutions, has scheduled a financial results conference for the third quarter of FY2025. The event will take place on Thursday, August 6, 2026, at 11:30 AM. The company is expected to present its financial performance and provide updates on its key business segments, including its exclusive distribution of the da Vinci robotic surgical systems, production of PET radiopharmaceuticals, and advancements in medical imaging and IT solutions.

The conference will offer insights into Synektik's ongoing initiatives, including its role as a major supplier of cutting-edge medical technologies and services to hospitals and clinics, as well as its efforts to maintain a competitive edge in the rapidly evolving healthcare technology market.

Relevance to Synektik S.A.: This announcement is directly tied to Synektik's business profile as it highlights the company's financial performance and strategic developments in its core areas of expertise, including robotic surgery systems and radiopharmaceuticals.

CBA Investigates Public Procurement in Mazovian Hospitals

The Central Anti-Corruption Bureau (CBA) has conducted searches in six hospitals across the Mazovian Voivodeship as part of an investigation into alleged irregularities in public procurement processes within healthcare facilities. The operation, supervised by the District Prosecutor's Office in Sieradz, focused on potential financial misconduct and the misuse of local government funds allocated for medical staff training and qualification enhancement during 2020–2021. Authorities have already detained three individuals and filed charges, with further procedural actions anticipated following the analysis of seized documents and data carriers.

Relevance to Synektik S.A.: As a key player in the medical technology and healthcare solutions market, Synektik S.A. operates in a sector where public procurement processes are critical. Investigations like this highlight the importance of transparency and compliance in securing contracts for advanced medical equipment and services, such as those provided by Synektik.

Synektik S.A. Loses Tender for Medical Equipment Supply Due to Higher Bid

Synektik S.A., a leading Polish medical technology company, has failed to secure a key tender for the supply of advanced medical equipment to a major healthcare institution. The tender was awarded to a competing firm that submitted the lowest bid, significantly undercutting Synektik's offer. Despite Synektik's reputation for providing cutting-edge medical solutions, including the da Vinci robotic surgical systems and radioisotope markers for diagnostic imaging, the company's higher pricing strategy proved to be a disadvantage in this competitive bidding process.

The loss of this tender highlights the growing competition in the medical technology market, particularly from lower-cost providers. This outcome could impact Synektik's market share and underscores the challenges the company faces in maintaining its leadership position amidst increasing price pressures.

Relevance to Synektik S.A.: This development is directly relevant to Synektik S.A.'s business profile as it reflects the competitive dynamics in the medical technology sector and the challenges the company faces in securing contracts against lower-cost competitors.

Synektik S.A. Reports Estimated 89% Revenue Growth in Q3 FY2025

Synektik S.A., a leading Polish medical technology company, has announced estimated consolidated revenues of approximately PLN 292.3 million for the third quarter of the 2025 financial year, marking an 89% year-on-year increase. For the first nine months of the fiscal year ending June 30, 2026, the company projects revenues of around PLN 733.4 million, reflecting a 52% growth compared to the same period last year.

The financial data, which remains preliminary, will be finalized and disclosed in the interim consolidated financial report scheduled for release on August 5, 2026. These results underscore Synektik's strong performance across its core business segments, including medical equipment distribution, IT solutions for healthcare, and radiopharmaceutical production.

Relevance: The article highlights Synektik S.A.'s robust financial growth, which aligns with its strategic focus on expanding its market presence in advanced medical technologies, including robotic surgical systems and radiopharmaceuticals.

Prof. Mariusz Kuśmierczyk Resigns as National Consultant in Cardiac Surgery Amid Heart Transplant Program Dispute

Prof. Dr. Hab. N. Med. Mariusz Kuśmierczyk has announced his resignation as the National Consultant in Cardiac Surgery and his departure from the National Transplant Council. The decision follows the Ministry of Health's approval to launch a third heart transplant program in Warsaw at the State Medical Institute of the Ministry of Internal Affairs and Administration (MSWiA), led by Prof. Piotr Suwalski. This marks the return of heart transplant procedures to the institute after a 21-year hiatus.

Prof. Kuśmierczyk, who also heads the Department of Cardiac Surgery, Thoracic Surgery, and Transplantology at the Medical University of Warsaw Clinical Center (UCK WUM), expressed concerns over prioritizing less experienced centers for such critical procedures. He stated, "If one has no influence, then why hold the position?" in his social media post explaining his resignation. Prof. Kuśmierczyk has held numerous prestigious roles, including President of the Polish Society of Cardio-Thoracic Surgeons (2018-2021), and was awarded the Knight's Cross of the Order of Polonia Restituta in 2016 for his contributions to heart transplantation.

National consultants play a crucial role in shaping healthcare policies, including initiating and evaluating epidemiological studies, forecasting medical needs, and advising on patient referrals for international treatments. The controversy surrounding the new transplant program highlights the complexities of healthcare decision-making in Poland.

Relevance to Synektik S.A.: The development of advanced cardiac surgery programs, such as heart transplants, aligns with Synektik S.A.'s focus on providing cutting-edge medical technologies, including robotic surgical systems like the da Vinci platform, which can enhance precision and outcomes in complex procedures.